Patterns of Chronic Use of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker in Pre-Dialysis Chronic Kidney Disease Patients with Anemia

被引：0
|
作者：
Yen, Chi-Tai [1 ,2 ]
Wang, Ming-Cheng [1 ,3 ]
Lin, Tzu-Chieh [1 ]
Yang, Yea-Huei Kao [1 ]
机构：
[1] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan
[2] Tainan Hosp, Minist Hlth & Welf, Tainan, Taiwan
[3] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
156
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [1] Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease
    Molnar, Miklos Z.
    Kalantar-Zadeh, Kamyar
    Lott, Evan H.
    Lu, Jun Ling
    Malakauskas, Sandra M.
    Ma, Jennie Z.
    Quarles, Darryl L.
    Kovesdy, Csaba P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (07) : 650 - 658
  • [2] EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE ACCORDING TO BACKGROUND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN RECEPTOR BLOCKER DOSE
    Heerspink, Hiddo Lambers
    Jong, Niels
    Stefansson, Bergur
    Chertow, Glenn
    Langkilde, Anna Maria
    Mcmurray, John
    Correa-Rotter, Ricardo
    Rossing, Peter
    Toto, Robert
    Wheeler, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I847 - I848
  • [3] The effect of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on mortality in patients with chronic kidney disease: a meta-analysis of observational studies
    Qin, Yuchen
    Chen, Tao
    Chen, Qi
    Lv, Jia Yi
    Qi, Na
    Wu, Cheng
    He, Jia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (05) : 503 - 511
  • [4] Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis
    Shen, Jenny I.
    Saxena, Anjali B.
    Montez-Rath, Maria E.
    Chang, Tara I.
    Winkelmayer, Wolfgang C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (05) : 862 - 869
  • [5] Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease
    Chen, Ping-Min
    Lai, Tai-Shuan
    Chen, Ping-Yu
    Lai, Chun-Fu
    Wu, VinCent
    Chiang, Wen-Chih
    Chen, Yung-Ming
    Wu, Kwan-Dun
    Tsai, Tun-Jun
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2014, 113 (04) : 219 - 226
  • [6] Proteinuria, Chronic Kidney Disease, and the Effect of an Angiotensin Receptor Blocker in Addition to an Angiotensin-Converting Enzyme Inhibitor in Patients With Moderate to Severe Heart Failure
    Anand, Inder S.
    Bishu, Kalkidan
    Rector, Thomas S.
    Ishani, Areef
    Kuskowski, Michael A.
    Cohn, Jay N.
    CIRCULATION, 2009, 120 (16) : 1577 - 1584
  • [7] Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease
    Toto, Robert
    Palmer, Biff F.
    AMERICAN JOURNAL OF NEPHROLOGY, 2008, 28 (03) : 372 - 380
  • [8] Angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use and outcomes in patients with colorectal cancer
    Tuazon, Sherilyn Alvaran
    King, Gantry Teng
    Cruz, Joanna Sta.
    Chae, Young K.
    Koc, Jean B. Ong Klan
    Hegarty, Sarah
    Leighton, John Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] ANGIOTENSIN RECEPTOR BLOCKER VERSUS ANGIOTENSIN-CONVERTING ENZYME INHIBITOR USE AND ALL-CAUSE MORTALITY IN HOSPITALIZED EELDERLY HEART FAILURE PATIENTS WITH CHRONIC KIDNEY DISEASE
    Ahmed, A.
    Allman, R.
    Aban, I.
    Sanders, P. W.
    Arnett, D. K.
    Love, T. E.
    Bakris, G. L.
    Rich, M. W.
    GERONTOLOGIST, 2009, 49 : 413 - 413
  • [10] Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease
    Ferrari, Paolo
    NEPHROLOGY, 2007, 12 (01) : 81 - 89
12345